1Turner G, Webb T, Wake S, et al . Prevalence of fragile X syndrome [J]. Am J Med Genet,1996,64 ( 1 ) :196 - 197.
2Verkerk AJ,et al. Identification of a gene ( FMR1 ) containing a CGG repeat coincident with a breskpoint cluster region exhibiting length variation in fragile X syndrome [ J ]. Cell, 1991,65 (5) :905.
4Tassone F, Hagerman RJ, Ikl -DN, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome[ J]. Am J Med Genet, 1999,84(3) :250 - 261.
5Loesch DZ, Huggins RM, Hagerman RJ. Phenotypic variation and FMRP levels in fragile X[ J]. Ment Retard Dev Disabil Res Rev,20lM, 10(1):31 - 41.
6Coffee B, Ikeda M, Budimirovic DB, et al. Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis [ J ]. Am J Med Genet A,2008,146A(10) :1358 - 1367.
8Willemsen R, Smits A, Mohkamsing S, et al. Rapid antibody test for diagnosing fragile X syndrome :a validation of the technique [ J]. Hum Genet, 1997,99 ( 3 ) :308 - 311.
9Scahill L, et al. A placebo - controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder[J]. Am J Psychiatry,2001,158(7) : 1067 - 1074.
10Torrioli MG, Vemacotola S, Peruzzi L, et al. A double - blind, parallel, muhicenter comparison of L - acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys[ J]. Am J Med Genet A,2008,146(7) :803 - 812.
二级参考文献2
1R. Willemsen,Arie Smits,Serieta Mohkamsing,H. van Beerendonk,Anton de Haan,B. de Vries,A. van den Ouweland,Erik Sistermans,Hans Galjaard,B. A. Oostra. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique[J] 1997,Human Genetics(3):308～311
2Luciana A. Haddad,Regina C. Mingroni-Netto,Angela M. Vianna-Morgante,Sérgio D. J. Pena. A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males[J] 1996,Human Genetics(6):808～812
2Levenga J, de Vrij FM, Oostra BA, et al. Potential therapeutic interventions for fragile X syndrome. Trends Mol Med. 2010; 16(11):516-527.
3Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991 ;66(4): 817-822.
4IliffAJ, Renoux A J, Krans A, et al. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice. Hum Mol Genet. 2013;22(6): 1180-1192.
5Kimura I, Nakayama Y, Zhao Y, et al. Neurotrophic effects of neudesin in the central nervous system. Front Neurosci. 2013;7:111.
6Budnik V, Salinas PC. Wnt signaling during synaptic development and plasticity. Curr Opin Neurobiol. 2011 ;21 (1): 151-159.
7D'Hulst C, Kooy RF. The GABAA receptoi~: a novel target for treatment of fragile X? Trends Neurosci. 2007;30(8):425-431.
8Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 5th ed. London: Academic Press,2005.
